CHICAGO — The Mayo Clinic will return to the taxable market for the second time in six months as low rates coupled with freedom from tax-exempt compliance issues are proving too good of an incentive to resist.

The Rochester, Minn.-based system will sell $300 million of taxable securities due in 2047 as soon as Tuesday, said the clinic’s manager of treasury services, Rick Haeflinger. Bank of America Merrill Lynch is the bookrunner and Wells Fargo Securities is co-senior manager. Raymond James is the financial adviser.

Subscribe Now

Independent and authoritative analysis and perspective for the bond buying industry.

14-Day Free Trial

No credit card required. Complete access to articles, breaking news and industry data.